8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.77%
Revenue growth at 50-75% of 3391.T's 12.21%. Martin Whitman would worry about competitiveness or product relevance.
11.04%
Gross profit growth above 1.5x 3391.T's 7.27%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
39.63%
EBIT growth similar to 3391.T's 41.86%. Walter Schloss might infer both firms share similar operational efficiencies.
44.97%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
44.92%
Net income growth at 75-90% of 3391.T's 51.72%. Bill Ackman would press for improvements to catch or surpass competitor performance.
44.95%
EPS growth at 75-90% of 3391.T's 51.40%. Bill Ackman would push for improved profitability or share repurchases to catch up.
44.95%
Diluted EPS growth at 75-90% of 3391.T's 51.36%. Bill Ackman would expect further improvements in net income or share count reduction.
0.00%
Share reduction more than 1.5x 3391.T's 0.21%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
59.52%
10Y CAGR of 59.52% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
59.52%
5Y CAGR of 59.52% while 3391.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
59.52%
3Y revenue/share CAGR above 1.5x 3391.T's 25.23%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
119.21%
10Y net income/share CAGR of 119.21% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
119.21%
Net income/share CAGR of 119.21% while 3391.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
119.21%
3Y net income/share CAGR 1.25-1.5x 3391.T's 106.84%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.94%
Inventory is declining while 3391.T stands at 3.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.12%
Similar asset growth to 3391.T's 2.25%. Walter Schloss finds parallel expansions or investment rates.
6.96%
BV/share growth above 1.5x 3391.T's 3.98%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-54.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.